SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000950170-24-053831
Filing Date
2024-05-06
Accepted
2024-05-06 20:00:07
Documents
2
Period of Report
2024-04-24

Document Format Files

Seq Description Document Type Size
1 3 ownership.html 3  
1 3 ownership.xml 3 23283
2 EX-24 srpt-ex24.htm EX-24 11974
  Complete submission text file 0000950170-24-053831.txt   36957
Mailing Address 215 FIRST STREET SUITE 415 CAMBRIDGE MA 02142
Business Address 215 FIRST STREET SUITE 415 CAMBRIDGE MA 02142 617-274-4000
Sarepta Therapeutics, Inc. (Issuer) CIK: 0000873303 (see all company filings)

IRS No.: 930797222 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 215 FIRST STREET CAMBRIDGE MA 02142
Business Address
Murray Dallan (Reporting) CIK: 0002022303 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-14895 | Film No.: 24919203